Surgical Innovations Group plc designs, develops, manufactures, and sells medical devices for use in minimally invasive surgery and precision engineering markets. It operates through three segments: SI Brand, Original Equipment Manufacturer (OEM), and Precision Engineering (PE). The SI Brand segment researches, develops, manufactures, and distributes minimally invasive devices. This segment also offers YelloPort Elite and YelloPort +plus laparoscopic port access systems; LogiRange resposable laparoscopic instrument systems; FastClamp laparoscopic clamping systems; and QuickRange single use laparoscopic instrumentation. The OEM segment researches, develops, manufactures, and distributes minimally invasive devices for third party medical device companies through own label, or co-branding. This segment also provides design and development solutions for producing a final device. The PE segment researches, develops, manufactures, and sells minimally invasive technology products for precision engineering applications. The company also designs and manufactures autologous blood products. It sells its products through independent healthcare distributors, as well as its own label products through OEM relationships. Surgical Innovations Group plc was founded in 1992 and is based in Leeds, the United Kingdom.
Industry, Sector and Symbol
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
SymbolLON:SUN
CUSIPN/A
Phone+44-113-2307597
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins8.68%
Return on Equity9.99%
Return on Assets8.63%
Miscellaneous
EmployeesN/A
Outstanding Shares782,360,000
Surgical Innovations Group (LON:SUN) Frequently Asked Questions
What is Surgical Innovations Group's stock symbol?
Surgical Innovations Group trades on the London Stock Exchange (LON) under the ticker symbol "SUN."
What price target have analysts set for SUN?
1 brokers have issued 1 year target prices for Surgical Innovations Group's shares. Their forecasts range from GBX 5.50 to GBX 5.50. On average, they expect Surgical Innovations Group's share price to reach GBX 5.50 in the next twelve months. View Analyst Ratings for Surgical Innovations Group.
Who are some of Surgical Innovations Group's key competitors?
Some companies that are related to Surgical Innovations Group include Ellex Medical Lasers (ELXMF), Creo Medical Group (CREO), Hamilton Thorne (HTL), Kromek Group (KMK), Electromed (ELMD), Universal Biosensors (UBI), Advanced Oncotherapy (AVO), Protech Home Medical (PHM), MRI Interventions (MRIC), NeuroOne Medical Tech (NMTC), PetVivo (PETV), Avacta Group (AVCT), Myomo (MYO), GI Dynamics (GID) and Airware Labs (AIRW).
Who are Surgical Innovations Group's key executives?
Surgical Innovations Group's management team includes the folowing people:
- Mr. Nigel F. Rogers FCA, Exec. Chairman (Age 56)
- Mrs. Melanie Ross, Chief Financial Officer, Chief Operating Officer and Director (Age 38)
- Mr. Adam Power, Group Devel. Director & Director
- Mr. David John Marsh, Group Commercial Director & Director
- Ms. Charmaine Day ACCA, Financial Controller and Company Sec. (Age 36)
Has Surgical Innovations Group been receiving favorable news coverage?
News articles about SUN stock have been trending somewhat positive this week, Accern Sentiment reports. The research firm identifies negative and positive news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Surgical Innovations Group earned a news sentiment score of 0.16 on Accern's scale. They also gave headlines about the company an impact score of 45.81 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.
How do I buy shares of Surgical Innovations Group?
Shares of SUN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Surgical Innovations Group's stock price today?
One share of SUN stock can currently be purchased for approximately GBX 2.85.
How big of a company is Surgical Innovations Group?
Surgical Innovations Group has a market capitalization of £31.75 million.
How can I contact Surgical Innovations Group?
Surgical Innovations Group's mailing address is Clayton Wood House, 6 Clayton Wood Bank, LEEDS, LS16 6QZ, United Kingdom. The company can be reached via phone at +44-113-2307597.
MarketBeat Community Rating for Surgical Innovations Group (SUN)
MarketBeat's community ratings are surveys of what our community members think about Surgical Innovations Group and other stocks. Vote "Outperform" if you believe SUN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SUN will underperform the S&P 500 over the long term. You may vote once every thirty days.
